Showing results (71-80 of 463) with videos related to
Sort By:
Pageof 47
American Journal of Cancer Research|June 13, 2022
MDM2/MDM4 amplification and CDKN2A deletion in metastatic melanoma and glioblastoma multiforme may have implications for targeted therapeutics and immunotherapyTaylor E Arnoff, Wafik S El-DeiryCancer Biology & Therapy|October 3, 2006
Taming NEMO to slay cancer cellsKimberly A Scata, Wafik S El-DeiryCurrent Opinion in Oncology|November 20, 2012
p21WAF1 and tumourigenesis: 20 years afterNoel A Warfel, Wafik S El-DeiryNature Reviews. Clinical Oncology|March 24, 2020
Targeting apoptosis in cancer therapyBenedito A Carneiro, Wafik S El-DeiryInternational Journal of Cancer|March 20, 1998
Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cellsM V Blagosklonny, W S El-DeiryBiochemical and Biophysical Research Communications|March 1, 2000
p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4S Q Xu, W S El-DeiryCurrent Opinion in Molecular Therapeutics|March 16, 2001
Novel strategies for therapeutic design in molecular oncology using gene expression profilesM S Ricci, W S el-DeiryThe Journal of Biological Chemistry|August 4, 2001
Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approachT F Burns, W S El-DeiryAdvances in Experimental Medicine and Biology|November 13, 2007
p53, BRCA1 and breast Cancer chemoresistanceKimberly A Scata, Wafik S El-DeiryMethods in Molecular Biology (Clifton, N.J.)|June 10, 2004
Cell cycle checkpoint control mechanisms that can be disrupted in cancerBipin C Dash, Wafik S El-DeiryPageof 47